ARS Pharmaceuticals, Inc. (SPRY)

ARS Pharmaceuticals experienced eighteen insider trading transactions over the past ninety days, all involving proposed sales totaling approximately 4.78 million dollars. Key officers, including Eric Karas and Richard Lowenthal, offloaded shares amid a 47.9% stock price decline. These divestments occurred following the most recent earnings report, which reflected a 5.88% earnings per share miss.
Ticker: SPRY Exchange: NMS


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for ARS Pharmaceuticals, Inc.. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
ERIC KARAS Officer Officer
Transaction date
Proposed sale
Price
61.50
Quantity 46,524
Value US$4,470,442
ERIC KARAS Officer Officer
Transaction date
Proposed sale
Price
283.26
Quantity 85,169
Value US$1,070,015
ERIC KARAS Officer Officer
Transaction date
Proposed sale
Price
390.04
Quantity 5,114
Value US$3,993,719
ERIC KARAS Officer Officer
Transaction date
Proposed sale
Price
4.26
Quantity 100,000
Value US$426,097
ERIC KARAS Officer Officer
Transaction date
Proposed sale
Price
4.32
Quantity 100,000
Value US$431,560
RICHARD LOWENTHAL Officer; Director; 10% Stockholder Executive Director Large shareholder
Transaction date
Proposed sale
Price
5.06
Quantity 35,000
Value US$176,995
ERIC KARAS Officer Officer
Transaction date
Proposed sale
Price
4.96
Quantity 14,064
Value US$69,762
RICHARD LOWENTHAL Officer; Director; 10% Stockholder Executive Director Large shareholder
Transaction date
Proposed sale
Price
5.61
Quantity 75,000
Value US$421,058
RICHARD LOWENTHAL Officer; Director; 10% Stockholder Executive Director Large shareholder
Transaction date
Proposed sale
Price
5.84
Quantity 19,805
Value US$115,564
RICHARD LOWENTHAL Officer; Director; 10% Stockholder Executive Director Large shareholder
Transaction date
Proposed sale
Price
5.95
Quantity 840
Value US$5,000
SARINA TANIMOTO Officer; 10% Stockholder Officer Large shareholder
Transaction date
Proposed sale
Price
6.01
Quantity 45,388
Value US$272,850
SARINA TANIMOTO Officer; 10% Stockholder Officer Large shareholder
Transaction date
Proposed sale
Price
5.82
Quantity 63,289
Value US$368,099
SARINA TANIMOTO Officer; 10% Stockholder Officer Large shareholder
Transaction date
Proposed sale
Price
5.92
Quantity 25,000
Value US$147,970
RICHARD LOWENTHAL Officer; Director; 10% Stockholder Executive Director Large shareholder
Transaction date
Proposed sale
Price
5.93
Quantity 25,000
Value US$148,160
SARINA TANIMOTO Officer; 10% Stockholder Officer Large shareholder
Transaction date
Proposed sale
Price
6.45
Quantity 25,000
Value US$161,170
RICHARD LOWENTHAL Officer; Director; 10% Stockholder Executive Director Large shareholder
Transaction date
Proposed sale
Price
6.45
Quantity 50,000
Value US$322,345
SARINA TANIMOTO Officer; 10% Stockholder Officer Large shareholder
Transaction date
Proposed sale
Price
6.30
Quantity 49,401
Value US$311,192
RICHARD LOWENTHAL Officer; Director; 10% Stockholder Executive Director Large shareholder
Transaction date
Proposed sale
Price
6.32
Quantity 50,000
Value US$315,885
Karas Eric Chief Commercial Officer Officer
Transaction date
Planned sale
Price
10.00
Quantity 25,000 -67.2%
Value US$250,000
3.3
Fitzpatrick Alexander A Chief Legal Officer Officer
Transaction date
Planned sale
Price
10.00
Quantity 3,355 -3.6%
Value US$33,550
ERIC KARAS Officer Officer
Transaction date
Proposed sale
Price
10.00
Quantity 25,000
Value US$250,000
3.3
ALEXANDER FITZPATRICK Officer Officer
Transaction date
Proposed sale
Price
10.00
Quantity 3,355
Value US$33,550
1.9
Dorsey Brian Chief Operating Officer Officer
Transaction date
Sale
Price
8.71
Quantity 21,828 -66.9%
Value US$190,050
1.9
BRIAN T DORSEY Officer Officer
Transaction date
Proposed sale
Price
8.71
Quantity 21,828
Value US$190,050
3.2
Chakma Justin Chief Business Officer Officer
Transaction date
Sale
Price
8.86
Quantity 136,380 -100.0%
Value US$1,208,790
3.2
Chakma Justin Chief Business Officer Officer
Transaction date
Sale
Price
8.91
Quantity 30,000 -18.0%
Value US$267,357
3.2
Chakma Justin Officer Officer
Transaction date
Proposed sale
Price
9.00
Quantity 136,380
Value US$1,227,420
3.2
Chakma Justin Officer Officer
Transaction date
Proposed sale
Price
8.87
Quantity 138,380
Value US$1,227,420
3.2
JUSTIN CHAKMA Officer Officer
Transaction date
Proposed sale
Price
8.91
Quantity 30,000
Value US$267,357
Lowenthal Richard E PRESIDENT AND CEO Executive Director Large shareholder
Transaction date
Planned sale
Price
14.49
Quantity 50,000 -4.0%
Value US$724,345
3.0
Scott Kathleen D. Chief Financial Officer Officer
Transaction date
Planned sale
Price
15.00
Quantity 12,500 -55.5%
Value US$187,500
3.0
KATHLEEN D SCOTT Officer Officer
Transaction date
Proposed sale
Price
15.00
Quantity 12,500
Value US$187,500
Lowenthal Richard E Officer; Director; Member of immediate family of any of the foregoing Executive Director
Transaction date
Proposed sale
Price
14.15
Quantity 150,000
Value US$2,123,000
Tanimoto Sarina CHIEF MEDICAL OFFICER Officer Large shareholder
Transaction date
Planned sale
Price
14.09
Quantity 37,656 -2.9%
Value US$530,626
Tanimoto Sarina CHIEF MEDICAL OFFICER Officer Large shareholder
Transaction date
Planned sale
Price
14.03
Quantity 12,344 -1.0%
Value US$173,130
Tanimoto Sarina Officer; Member of immediate family of any of the foregoing Officer
Transaction date
Proposed sale
Price
14.00
Quantity 150,000
Value US$2,100,000
Karas Eric Chief Commercial Officer Officer
Transaction date
Planned sale
Price
16.99
Quantity 15,000 -59.3%
Value US$254,860
ERIC KARAS Officer Officer
Transaction date
Proposed sale
Price
16.99
Quantity 15,000
Value US$254,859
2.8
Flynn James E Large shareholder
Transaction date
Sale
Price
18.46
Quantity 370,074 -7.0%
Value US$6,831,566
2.8
Flynn James E Large shareholder
Transaction date
Sale
Price
18.46
Quantity 370,075 -7.0%
Value US$6,831,584
Karas Eric Chief Commercial Officer Officer
Transaction date
Planned sale
Price
16.00
Quantity 15,000 -66.1%
Value US$240,000
ERIC KARAS Officer Officer
Transaction date
Proposed sale
Price
16.00
Quantity 15,000
Value US$240,000
3.1
SAUNDERS BRENT L Non-Executive Director
Transaction date
Sale
Price
14.25
Quantity 120,000 -100.0%
Value US$1,710,024
3.0
Scott Kathleen D. Chief Financial Officer Officer
Transaction date
Sale
Price
14.10
Quantity 50,000 -87.1%
Value US$705,165
3.3
Fitzpatrick Alexander A Chief Legal Officer Officer
Transaction date
Sale
Price
14.10
Quantity 102,969 -53.5%
Value US$1,451,513
3.0
Scott Kathleen D. Officer Officer
Transaction date
Proposed sale
Price
14.10
Quantity 50,000
Value US$705,000
3.3
Fitzpatrick Alexander A Officer Officer
Transaction date
Proposed sale
Price
14.02
Quantity 102,969
Value US$1,443,894
3.1
SAUNDERS BRENT L Director Non-Executive Director
Transaction date
Proposed sale
Price
14.25
Quantity 120,000
Value US$1,710,000
0.5
Shawver Laura Non-Executive Director
Transaction date
Planned sale
Price
12.30
Quantity 50,002 -19.2%
Value US$615,075
0.5
Shawver Laura Director Non-Executive Director
Transaction date
Proposed sale
Price
12.30
Quantity 50,002
Value US$615,051
Karas Eric Chief Commercial Officer Officer
Transaction date
Planned sale
Price
14.00
Quantity 10,000 -56.5%
Value US$140,000
ERIC KARAS Officer Officer
Transaction date
Proposed sale
Price
14.00
Quantity 10,000
Value US$140,000
0.5
Shawver Laura Non-Executive Director
Transaction date
Planned sale
Price
11.21
Quantity 49,600 -19.1%
Value US$556,046
0.5
Shawver Laura Non-Executive Director
Transaction date
Planned sale
Price
11.00
Quantity 400 -0.2%
Value US$4,400
0.5
Shawver Laura Director Non-Executive Director
Transaction date
Proposed sale
Price
11.00
Quantity 50,000
Value US$550,000
0.5
Shawver Laura Non-Executive Director
Transaction date
Planned sale
Price
12.31
Quantity 50,000 -19.2%
Value US$615,565
0.5
Shawver Laura Director Non-Executive Director
Transaction date
Proposed sale
Price
12.31
Quantity 50,000
Value US$615,565
0.5
Shawver Laura Non-Executive Director
Transaction date
Planned sale
Price
11.10
Quantity 50,000 -19.2%
Value US$555,065
0.5
Shawver Laura Director Non-Executive Director
Transaction date
Proposed sale
Price
11.10
Quantity 50,000
Value US$555,065
Tanimoto Sarina CHIEF MEDICAL OFFICER Officer Large shareholder
Transaction date
Planned sale
Price
11.67
Quantity 50,000 -4.4%
Value US$583,525
Tanimoto Sarina CHIEF MEDICAL OFFICER Officer Large shareholder
Transaction date
Planned sale
Price
11.67
Quantity 50,000 -3.7%
Value US$583,575
Lowenthal Richard E PRESIDENT AND CEO Executive Director Large shareholder
Transaction date
Planned sale
Price
11.67
Quantity 50,000 -4.4%
Value US$583,525
Lowenthal Richard E PRESIDENT AND CEO Executive Director Large shareholder
Transaction date
Planned sale
Price
11.67
Quantity 50,000 -3.7%
Value US$583,575
3.2
Chakma Justin Officer Officer
Transaction date
Proposed sale
Price
12.06
Quantity 27,272
Value US$328,967
3.2
Chakma Justin Chief Business Officer Officer
Transaction date
Sale
Price
12.06
Quantity 27,272 -16.7%
Value US$328,968
1.9
Dorsey Brian Chief Operating Officer Officer
Transaction date
Sale
Price
12.30
Quantity 25,000 -80.6%
Value US$307,432
3.2
Chakma Justin Chief Business Officer Officer
Transaction date
Sale
Price
12.27
Quantity 117,333 -46.2%
Value US$1,439,124
1.9
Dorsey Brian Chief Operating Officer Officer
Transaction date
Planned sale
Price
12.43
Quantity 15,000 -71.3%
Value US$186,426
1.9
Dorsey Brian Officer Officer
Transaction date
Proposed sale
Price
13.31
Quantity 61,200
Value US$814,572
3.2
Chakma Justin Officer Officer
Transaction date
Proposed sale
Price
11.50
Quantity 117,333
Value US$1,349,330
3.2
Chakma Justin Chief Business Officer Officer
Transaction date
Sale
Price
13.15
Quantity 50,000 -26.8%
Value US$657,625
Tanimoto Sarina CHIEF MEDICAL OFFICER Officer Large shareholder
Transaction date
Planned sale
Price
13.16
Quantity 50,000 -4.2%
Value US$658,155
Tanimoto Sarina CHIEF MEDICAL OFFICER Officer Large shareholder
Transaction date
Planned sale
Price
13.17
Quantity 50,000 -3.9%
Value US$658,265
Lowenthal Richard E PRESIDENT AND CEO Executive Director Large shareholder
Transaction date
Planned sale
Price
13.16
Quantity 50,000 -4.2%
Value US$658,155
Lowenthal Richard E PRESIDENT AND CEO Executive Director Large shareholder
Transaction date
Planned sale
Price
13.17
Quantity 50,000 -3.9%
Value US$658,265
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-11-09 2026-11-09 PrS Proposed sale

Officer

Officer
46,524
61.50
US$4,470,442
46,524 61.50 US$4,470,442
2026-10-30 2026-10-30 PrS Proposed sale

Officer

Officer
85,169
283.26
US$1,070,015
85,169 283.26 US$1,070,015
2026-10-19 2026-10-19 PrS Proposed sale

Officer

Officer
5,114
390.04
US$3,993,719
5,114 390.04 US$3,993,719
2026-10-01 2026-10-01 PrS Proposed sale

Officer

Officer
100,000
4.26
US$426,097
100,000 4.26 US$426,097
2026-09-30 2026-09-30 PrS Proposed sale

Officer

Officer
100,000
4.32
US$431,560
100,000 4.32 US$431,560
2026-09-11 2026-09-11 PrS Proposed sale

Officer; Director; 10% Stockholder

Executive Director Large shareholder
35,000
5.06
US$176,995
35,000 5.06 US$176,995
2026-09-11 2026-09-11 PrS Proposed sale

Officer

Officer
14,064
4.96
US$69,762
14,064 4.96 US$69,762
2026-09-04 2026-09-04 PrS Proposed sale

Officer; Director; 10% Stockholder

Executive Director Large shareholder
75,000
5.61
US$421,058
75,000 5.61 US$421,058
2026-09-03 2026-09-03 PrS Proposed sale

Officer; Director; 10% Stockholder

Executive Director Large shareholder
19,805
5.84
US$115,564
19,805 5.84 US$115,564
2026-09-02 2026-09-02 PrS Proposed sale

Officer; Director; 10% Stockholder

Executive Director Large shareholder
840
5.95
US$5,000
840 5.95 US$5,000
2026-09-01 2026-09-01 PrS Proposed sale

Officer; 10% Stockholder

Officer Large shareholder
45,388
6.01
US$272,850
45,388 6.01 US$272,850
2026-08-31 2026-08-31 PrS Proposed sale

Officer; 10% Stockholder

Officer Large shareholder
63,289
5.82
US$368,099
63,289 5.82 US$368,099
2026-08-20 2026-08-20 PrS Proposed sale

Officer; 10% Stockholder

Officer Large shareholder
25,000
5.92
US$147,970
25,000 5.92 US$147,970
2026-08-20 2026-08-20 PrS Proposed sale

Officer; Director; 10% Stockholder

Executive Director Large shareholder
25,000
5.93
US$148,160
25,000 5.93 US$148,160
2026-08-19 2026-08-19 PrS Proposed sale

Officer; 10% Stockholder

Officer Large shareholder
25,000
6.45
US$161,170
25,000 6.45 US$161,170
2026-08-19 2026-08-19 PrS Proposed sale

Officer; Director; 10% Stockholder

Executive Director Large shareholder
50,000
6.45
US$322,345
50,000 6.45 US$322,345
2026-08-18 2026-08-18 PrS Proposed sale

Officer; 10% Stockholder

Officer Large shareholder
49,401
6.30
US$311,192
49,401 6.30 US$311,192
2026-08-18 2026-08-18 PrS Proposed sale

Officer; Director; 10% Stockholder

Executive Director Large shareholder
50,000
6.32
US$315,885
50,000 6.32 US$315,885
2026-06-12 2026-06-12 PlS Planned sale

Chief Commercial Officer

Officer
25,000 -67.2%
10.00
US$250,000
25,000 -67.2% 10.00 US$250,000
2026-06-12 2026-06-12 PlS Planned sale

Chief Legal Officer

Officer
3,355 -3.6%
10.00
US$33,550
3,355 -3.6% 10.00 US$33,550
2026-06-12 2026-06-12 PrS Proposed sale

Officer

Officer
25,000
10.00
US$250,000
25,000 10.00 US$250,000
2026-06-12 2026-06-12 PrS Proposed sale

Officer

Officer
3,355
10.00
US$33,550
3,355 10.00 US$33,550
2025-11-14 2025-11-13 S Sale

Chief Operating Officer

Officer
21,828 -66.9%
8.71
US$190,050
21,828 -66.9% 8.71 US$190,050
2025-11-13 2025-11-13 PrS Proposed sale

Officer

Officer
21,828
8.71
US$190,050
21,828 8.71 US$190,050
2025-11-14 2025-11-12 S Sale

Chief Business Officer

Officer
136,380 -100.0%
8.86
US$1,208,790
136,380 -100.0% 8.86 US$1,208,790
2025-11-14 2025-11-12 S Sale

Chief Business Officer

Officer
30,000 -18.0%
8.91
US$267,357
30,000 -18.0% 8.91 US$267,357
2025-11-12 2025-11-12 PrS Proposed sale

Officer

Officer
136,380
9.00
US$1,227,420
136,380 9.00 US$1,227,420
2025-11-12 2025-11-12 PrS Proposed sale

Officer

Officer
138,380
8.87
US$1,227,420
138,380 8.87 US$1,227,420
2025-11-12 2025-11-12 PrS Proposed sale

Officer

Officer
30,000
8.91
US$267,357
30,000 8.91 US$267,357
2025-08-22 2025-08-21 PlS Planned sale

PRESIDENT AND CEO

Executive Director Large shareholder
50,000 -4.0%
14.49
US$724,345
50,000 -4.0% 14.49 US$724,345
2025-08-22 2025-08-21 PlS Planned sale

Chief Financial Officer

Officer
12,500 -55.5%
15.00
US$187,500
12,500 -55.5% 15.00 US$187,500
2025-08-21 2025-08-21 PrS Proposed sale

Officer

Officer
12,500
15.00
US$187,500
12,500 15.00 US$187,500
2025-08-21 2025-08-21 PrS Proposed sale

Officer; Director; Member of immediate family of any of the foregoing

Executive Director
150,000
14.15
US$2,123,000
150,000 14.15 US$2,123,000
2025-08-21 2025-08-20 PlS Planned sale

CHIEF MEDICAL OFFICER

Officer Large shareholder
37,656 -2.9%
14.09
US$530,626
37,656 -2.9% 14.09 US$530,626
2025-08-21 2025-08-19 PlS Planned sale

CHIEF MEDICAL OFFICER

Officer Large shareholder
12,344 -1.0%
14.03
US$173,130
12,344 -1.0% 14.03 US$173,130
2025-08-19 2025-08-19 PrS Proposed sale

Officer; Member of immediate family of any of the foregoing

Officer
150,000
14.00
US$2,100,000
150,000 14.00 US$2,100,000
2025-07-03 2025-07-01 PlS Planned sale

Chief Commercial Officer

Officer
15,000 -59.3%
16.99
US$254,860
15,000 -59.3% 16.99 US$254,860
2025-07-01 2025-07-01 PrS Proposed sale

Officer

Officer
15,000
16.99
US$254,859
15,000 16.99 US$254,859
2025-07-01 2025-06-27 S Sale Large shareholder
370,074 -7.0%
18.46
US$6,831,566
370,074 -7.0% 18.46 US$6,831,566
2025-07-01 2025-06-27 S Sale Large shareholder
370,075 -7.0%
18.46
US$6,831,584
370,075 -7.0% 18.46 US$6,831,584
2025-06-20 2025-06-18 PlS Planned sale

Chief Commercial Officer

Officer
15,000 -66.1%
16.00
US$240,000
15,000 -66.1% 16.00 US$240,000
2025-06-18 2025-06-18 PrS Proposed sale

Officer

Officer
15,000
16.00
US$240,000
15,000 16.00 US$240,000
2025-05-22 2025-05-20 S Sale Non-Executive Director
120,000 -100.0%
14.25
US$1,710,024
120,000 -100.0% 14.25 US$1,710,024
2025-05-22 2025-05-20 S Sale

Chief Financial Officer

Officer
50,000 -87.1%
14.10
US$705,165
50,000 -87.1% 14.10 US$705,165
2025-05-22 2025-05-20 S Sale

Chief Legal Officer

Officer
102,969 -53.5%
14.10
US$1,451,513
102,969 -53.5% 14.10 US$1,451,513
2025-05-20 2025-05-20 PrS Proposed sale

Officer

Officer
50,000
14.10
US$705,000
50,000 14.10 US$705,000
2025-05-20 2025-05-20 PrS Proposed sale

Officer

Officer
102,969
14.02
US$1,443,894
102,969 14.02 US$1,443,894
2025-05-20 2025-05-20 PrS Proposed sale

Director

Non-Executive Director
120,000
14.25
US$1,710,000
120,000 14.25 US$1,710,000
2025-04-08 2025-04-07 PlS Planned sale Non-Executive Director
50,002 -19.2%
12.30
US$615,075
50,002 -19.2% 12.30 US$615,075
2025-04-07 2025-04-07 PrS Proposed sale

Director

Non-Executive Director
50,002
12.30
US$615,051
50,002 12.30 US$615,051
2025-03-21 2025-03-20 PlS Planned sale

Chief Commercial Officer

Officer
10,000 -56.5%
14.00
US$140,000
10,000 -56.5% 14.00 US$140,000
2025-03-20 2025-03-20 PrS Proposed sale

Officer

Officer
10,000
14.00
US$140,000
10,000 14.00 US$140,000
2025-03-07 2025-03-06 PlS Planned sale Non-Executive Director
49,600 -19.1%
11.21
US$556,046
49,600 -19.1% 11.21 US$556,046
2025-03-07 2025-03-05 PlS Planned sale Non-Executive Director
400 -0.2%
11.00
US$4,400
400 -0.2% 11.00 US$4,400
2025-03-05 2025-03-05 PrS Proposed sale

Director

Non-Executive Director
50,000
11.00
US$550,000
50,000 11.00 US$550,000
2025-02-04 2025-02-03 PlS Planned sale Non-Executive Director
50,000 -19.2%
12.31
US$615,565
50,000 -19.2% 12.31 US$615,565
2025-02-03 2025-02-03 PrS Proposed sale

Director

Non-Executive Director
50,000
12.31
US$615,565
50,000 12.31 US$615,565
2025-01-07 2025-01-06 PlS Planned sale Non-Executive Director
50,000 -19.2%
11.10
US$555,065
50,000 -19.2% 11.10 US$555,065
2025-01-06 2025-01-06 PrS Proposed sale

Director

Non-Executive Director
50,000
11.10
US$555,065
50,000 11.10 US$555,065
2024-12-19 2024-12-17 PlS Planned sale

CHIEF MEDICAL OFFICER

Officer Large shareholder
50,000 -4.4%
11.67
US$583,525
50,000 -4.4% 11.67 US$583,525
2024-12-19 2024-12-17 PlS Planned sale

CHIEF MEDICAL OFFICER

Officer Large shareholder
50,000 -3.7%
11.67
US$583,575
50,000 -3.7% 11.67 US$583,575
2024-12-19 2024-12-17 PlS Planned sale

PRESIDENT AND CEO

Executive Director Large shareholder
50,000 -4.4%
11.67
US$583,525
50,000 -4.4% 11.67 US$583,525
2024-12-19 2024-12-17 PlS Planned sale

PRESIDENT AND CEO

Executive Director Large shareholder
50,000 -3.7%
11.67
US$583,575
50,000 -3.7% 11.67 US$583,575
2024-12-13 2024-12-13 PrS Proposed sale

Officer

Officer
27,272
12.06
US$328,967
27,272 12.06 US$328,967
2024-12-13 2024-12-13 S Sale

Chief Business Officer

Officer
27,272 -16.7%
12.06
US$328,968
27,272 -16.7% 12.06 US$328,968
2024-12-13 2024-12-12 S Sale

Chief Operating Officer

Officer
25,000 -80.6%
12.30
US$307,432
25,000 -80.6% 12.30 US$307,432
2024-12-13 2024-12-12 S Sale

Chief Business Officer

Officer
117,333 -46.2%
12.27
US$1,439,124
117,333 -46.2% 12.27 US$1,439,124
2024-12-13 2024-12-11 PlS Planned sale

Chief Operating Officer

Officer
15,000 -71.3%
12.43
US$186,426
15,000 -71.3% 12.43 US$186,426
2024-12-11 2024-12-11 PrS Proposed sale

Officer

Officer
61,200
13.31
US$814,572
61,200 13.31 US$814,572
2024-12-12 2024-12-10 PrS Proposed sale

Officer

Officer
117,333
11.50
US$1,349,330
117,333 11.50 US$1,349,330
2024-12-12 2024-12-10 S Sale

Chief Business Officer

Officer
50,000 -26.8%
13.15
US$657,625
50,000 -26.8% 13.15 US$657,625
2024-12-11 2024-12-10 PlS Planned sale

CHIEF MEDICAL OFFICER

Officer Large shareholder
50,000 -4.2%
13.16
US$658,155
50,000 -4.2% 13.16 US$658,155
2024-12-11 2024-12-10 PlS Planned sale

CHIEF MEDICAL OFFICER

Officer Large shareholder
50,000 -3.9%
13.17
US$658,265
50,000 -3.9% 13.17 US$658,265
2024-12-11 2024-12-10 PlS Planned sale

PRESIDENT AND CEO

Executive Director Large shareholder
50,000 -4.2%
13.16
US$658,155
50,000 -4.2% 13.16 US$658,155
2024-12-11 2024-12-10 PlS Planned sale

PRESIDENT AND CEO

Executive Director Large shareholder
50,000 -3.9%
13.17
US$658,265
50,000 -3.9% 13.17 US$658,265

See older ARS Pharmaceuticals, Inc. insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock ARS Pharmaceuticals, Inc. history with Plus

Billed monthly · Cancel anytime